BATON ROUGE, La., Nov. 01, 2022 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), a number one supplier of high quality house well being, hospice, private care and high-acuity care, issued the next assertion following the CY 2023 Home Health Final Rule by the Centers for Medicare and Medicaid Services (CMS).
“While not the ideal outcome, today’s release of the CY 2023 Home Health Final Rule is a welcomed improvement over what was proposed by CMS this summer in regard to the overall payment update for next year. The unprecedent inflation we are experiencing across the country led to a 4.0% market basket update, the highest update we have seen for home health agencies. CMS’s decision to reduce the behavioral adjustment cuts calculated by half for CY 2023 is also helpful, and one that was undoubtedly impacted by the significant volume of comments and advocacy conducted over the last six months by home health providers, our dedicated clinicians, patient advocacy groups, trade associations and Members of Congress. We thank our champions in Congress for their steadfast support and we also thank the Administrator and the team at CMS for the changes made in the Final Rule. However, we still have serious concerns regarding the agency’s continued reliance on a flawed budget neutrality methodology that produced the Proposed Rule and today’s result.
Amedisys looks forward to joining our industry colleagues in working with our home health champions in Congress to ensure that Medicare payment policy for home health services accomplishes the budget neutrality requirements set forth and contemplated by Congress.”
About Amedisys:
Amedisys, Inc. is a number one healthcare at house Company delivering personalised house well being, hospice, private care and high-acuity care providers. Amedisys is concentrated on delivering the care that’s finest for our sufferers, whether or not that’s home-based private care; inpatient hospital, palliative, and expert nursing facility (“SNF”) care of their houses; restoration and rehabilitation after an operation or damage; care targeted on empowering them to handle a continual illness; or hospice care on the finish of life. More than 3,000 hospitals and 90,000 physicians nationwide have chosen Amedisys as a accomplice in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an government workplace in Nashville, TN, Amedisys is a publicly held firm. With roughly 21,000 staff, in 547 care facilities in 36 states and the District of Columbia, Amedisys is devoted to delivering the very best high quality of care to the doorsteps of greater than 445,000 sufferers in want yearly, performing greater than 11.5 million visits yearly. For extra details about the Company, please go to: www.amedisys.com.
